HK1247636A1 - Rna指導的人類jc病毒和其他多瘤病毒的根除 - Google Patents

Rna指導的人類jc病毒和其他多瘤病毒的根除

Info

Publication number
HK1247636A1
HK1247636A1 HK18106893.5A HK18106893A HK1247636A1 HK 1247636 A1 HK1247636 A1 HK 1247636A1 HK 18106893 A HK18106893 A HK 18106893A HK 1247636 A1 HK1247636 A1 HK 1247636A1
Authority
HK
Hong Kong
Prior art keywords
polyomaviruses
eradication
virus
human
rna guided
Prior art date
Application number
HK18106893.5A
Other languages
English (en)
Inventor
K．卡利里
W.胡
H．沃勒勃
Original Assignee
英聯邦高等教育系統天普大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 英聯邦高等教育系統天普大學 filed Critical 英聯邦高等教育系統天普大學
Publication of HK1247636A1 publication Critical patent/HK1247636A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
HK18106893.5A 2014-10-30 2018-05-25 Rna指導的人類jc病毒和其他多瘤病毒的根除 HK1247636A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462072927P 2014-10-30 2014-10-30
US201562169390P 2015-06-01 2015-06-01
US201562169638P 2015-06-02 2015-06-02
PCT/US2015/058351 WO2016070070A1 (en) 2014-10-30 2015-10-30 Rna guided eradication of human jc virus and other polyomaviruses

Publications (1)

Publication Number Publication Date
HK1247636A1 true HK1247636A1 (zh) 2018-09-28

Family

ID=55858408

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18106893.5A HK1247636A1 (zh) 2014-10-30 2018-05-25 Rna指導的人類jc病毒和其他多瘤病毒的根除

Country Status (11)

Country Link
US (2) US20170333572A1 (zh)
EP (1) EP3212795A4 (zh)
CN (2) CN115044570A (zh)
AU (1) AU2015338993B2 (zh)
CA (1) CA2967990C (zh)
HK (1) HK1247636A1 (zh)
MA (1) MA40880A (zh)
MX (1) MX2017005672A (zh)
RU (1) RU2747722C2 (zh)
WO (1) WO2016070070A1 (zh)
ZA (1) ZA201703163B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853829C (en) 2011-07-22 2023-09-26 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
WO2013163628A2 (en) 2012-04-27 2013-10-31 Duke University Genetic correction of mutated genes
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US20150166982A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting pi3k point mutations
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
EP4269577A3 (en) 2015-10-23 2024-01-17 President and Fellows of Harvard College Nucleobase editors and uses thereof
CA3006305A1 (en) 2015-12-09 2017-06-15 Excision Biotherapeutics, Inc. Gene editing methods and compositions for eliminating risk of jc virus activation and pml (progressive multifocal leukoencephalopathy) during immunosuppressive therapy
CN108603196A (zh) * 2016-01-25 2018-09-28 酶切生物技术公司 Rna向导的对人类jc病毒和其他多瘤病毒的根除
WO2017196768A1 (en) * 2016-05-09 2017-11-16 President And Fellows Of Harvard College Self-targeting guide rnas in crispr system
CA3018294A1 (en) * 2016-06-01 2017-12-07 Excision Biotherapeutics, Inc. Compositions and methods of treatment for lytic and lysogenic viruses
EP3487523B1 (en) * 2016-07-19 2023-09-06 Duke University Therapeutic applications of cpf1-based genome editing
SG11201900907YA (en) 2016-08-03 2019-02-27 Harvard College Adenosine nucleobase editors and uses thereof
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN110214180A (zh) 2016-10-14 2019-09-06 哈佛大学的校长及成员们 核碱基编辑器的aav递送
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
EP3592777A1 (en) 2017-03-10 2020-01-15 President and Fellows of Harvard College Cytosine to guanine base editor
CN110914426A (zh) 2017-03-23 2020-03-24 哈佛大学的校长及成员们 包含核酸可编程dna结合蛋白的核碱基编辑器
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
JP2021500036A (ja) 2017-10-16 2021-01-07 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. アデノシン塩基編集因子の使用
BR112021018607A2 (pt) 2019-03-19 2021-11-23 Massachusetts Inst Technology Métodos e composições para editar sequências de nucleotídeos
US20220380812A1 (en) * 2019-11-11 2022-12-01 Temple University - Of The Commonwealth System Of Higher Education Crispr/cas9 system as an agent for inhibition of polyoma jc infection
CN116096873A (zh) 2020-05-08 2023-05-09 布罗德研究所股份有限公司 同时编辑靶标双链核苷酸序列的两条链的方法和组合物
CN112322587A (zh) * 2020-09-17 2021-02-05 杭州市第一人民医院 一种带Cas9基因的人源可诱导多能干细胞系、构建方法、鉴定方法及应用
RU2747819C1 (ru) * 2020-11-30 2021-05-14 Федеральное бюджетное учреждение науки «Центральный научно-исследовательский институт эпидемиологии» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) Способ получения препарата рибонуклеопротеинового комплекса CRISPR/Cas и препарат для выявления ДНК вируса Джона Каннингема (JCPyV) в ультранизких концентрациях
RU2747820C1 (ru) * 2020-11-30 2021-05-14 Федеральное бюджетное учреждение науки «Центральный научно-исследовательский институт эпидемиологии» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) Система CRISPR-Cas для выявления ДНК вируса Джона Каннингема (JCPyV) в ультранизких концентрациях

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
WO2007127919A2 (en) * 2006-04-28 2007-11-08 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a gene from the jc virus
EP2946015B1 (en) * 2013-01-16 2021-05-26 Emory University Cas9-nucleic acid complexes and uses related thereto

Also Published As

Publication number Publication date
US20170333572A1 (en) 2017-11-23
RU2017115838A3 (zh) 2018-11-30
EP3212795A4 (en) 2018-06-27
MA40880A (fr) 2017-09-05
CN107406854B (zh) 2022-03-11
CN115044570A (zh) 2022-09-13
CA2967990A1 (en) 2016-05-06
AU2015338993A1 (en) 2017-05-25
EP3212795A1 (en) 2017-09-06
ZA201703163B (en) 2019-03-27
RU2747722C2 (ru) 2021-05-13
AU2015338993B2 (en) 2021-12-09
CA2967990C (en) 2024-02-13
CN107406854A (zh) 2017-11-28
RU2017115838A (ru) 2018-11-30
MX2017005672A (es) 2018-11-09
WO2016070070A1 (en) 2016-05-06
US20230001016A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
HK1247636A1 (zh) Rna指導的人類jc病毒和其他多瘤病毒的根除
EP3408392A4 (en) RNA-induced clearance of the human JC-virus and other polymorphs
HK1246355A1 (zh) 腺相關病毒變體及其使用方法
IL283258A (en) A preparation for the treatment of hypothyroidism
PL3349783T3 (pl) Kompozycje i sposoby do leczenia chorób
GB201519858D0 (en) Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
IL259246A (en) Preparations containing pharmaceutical substances and methods of using them
SG11201606624WA (en) Antibody moleules to dengue virus and uses thereof
IL256515A (en) Therapeutic peptides and methods of use thereof
BR112017002074A2 (pt) vestuário e método de compressão médica terapêutica
IL284236A (en) Modifications and uses of conotoxin peptides
HK1249118A1 (zh) 原毒素-ii變體及使用方法
HK1247091A1 (zh) 治療抗體及其用途
HK1250476A1 (zh) 原毒素-ii變體及使用方法
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
HK1256368A1 (zh) 加利車黴素-抗體-藥物綴合物和使用方法
SG11201510266SA (en) Dengue virus vaccine compositions and methods of use thereof
HK1258056A1 (zh) 治療性化合物和其使用方法
SG11201704942QA (en) Dengue virus vaccine compositions and methods of use thereof
GB201511799D0 (en) Composition and methods of treatment
SG11201605440TA (en) Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
GB2558547B (en) Actuatable paddle and methods of use
EP2943593A4 (en) DIAGNOSIS AND TREATMENT OF VIRUS DISEASES
ZA201802201B (en) Novel formulation and treatment methods
IL247448A0 (en) Peptides and methods of use